Selective increase of neuronal cyclooxygenase-2 (COX-2) expression in vulnerable brain regions of rats with experimental Wernicke's encephalopathy: Effect of nimesulide

Metabolic Brain Disease

Volumn 23, Issue 2, 2008, Pages 175-187

  Gu, Baoying ^a   Desjardins, Paul ^a   Butterworth, Roger F ^a  

^a Neuroscience Research Unit   (Canada)

Author keywords

Cyclooxygenase 2; Oxidative stress; Prostaglandins; Thiamine deficiency; Wernicke's encephalopathy

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; NIMESULIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN REGION; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FRONTAL CORTEX; IMMUNOREACTIVITY; INFERIOR COLLICULUS; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; THALAMUS; THIAMINE DEFICIENCY; WERNICKE ENCEPHALOPATHY;

ANIMALS; BRAIN; CYCLOOXYGENASE 2; CYTOPROTECTION; DINOPROSTONE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SULFONAMIDES; THIAMINE DEFICIENCY; UP-REGULATION; WERNICKE ENCEPHALOPATHY;

ANIMALIA; RATTUS;

EID: 44449088956     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-008-9089-2     Document Type: Article

References (41)

1. Aikawa H, Watanabe IS, Furuse T, Iwasaki Y, Satoyoshi E, Sumi T, Moroji T (1984) Low energy level in thiamine-deficient encephalopathy. J Neuropathol Exp Neurol 43:276-287
2. Baik EJ, Kim EJ, Lee SH, Moon C (1999) Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res 843:118-29
3. 2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol 56:240-248
4. Butterworth RF, Héroux M (1989) Effect of pyrithiamine treatment and subsequent thiamine rehabilitation on regional cerebral amino acids and thiamine-dependent enzymes. J Neurochem 52:1079-1084
5. Calingasan N, Baker H, Sheu K-FR, Gibson GE (1995) Blood-brain abnormalities in vulnerable brain regions during thiamine deficiency. Exp Neurol 134:64-72
6. Candelario-Jalil E, Alvarez D, Gonzalez-Falcon A, Garcia-Cabrera M, Martinez-Sanchez G, Merino N, Giuliani A, Leon OS (2002) Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia. Eur J Pharmacol 453:189-195
7. Cernak I, O'Connor C, Vink R (2002) Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Exp Brain Res 147:193-199
8. Desjardins P, Butterworth RF (2005) Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke's encephalopathy. Mol Neurobiol 31:17-25
9. Drachman DB, Rothstein JD (2000) Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol 48:792-795
10. Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D (1993) Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 307:361-368
11. Gendron TF, Brunette E, Mealing GA, Nguyen A, Tauskela JS, Morley P (2004) Opposing effects of cyclooxygenase-2 selective inhibitors on oxygen-glucose deprivation-induced neurotoxicity. Eur J Pharmacol 493:45-55
12. 2 in excitotoxicity and preconditioning-induced neuroprotection. Eur J Pharmacol 517:17-27
13. Gibson GE, Ksiezak-Reding H, Sheu K-FR, Mykytyn V, Blass JP (1984) Correlation of enzymatic, metabolic and behavioral deficits in thiamine deficiency and its reversal. Neurochem Res 9:803-814
14. Harper CG, Butterworth RF (1997) Nutritional and metabolic disorders. In: Graham DI, Lantos PL (eds) Greenfield's Neuropathology. Arnold, London, UK, pp 601-655
15. Hazell AS, Butterworth RF, Hakim AM (1993) Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency. J Neurochem 61:1155-1158
16. Hazell AS, Hakim AM, Senterman MK, Hogan MJ (1998) Regional activation of L-type voltage-sensitive calcium channels in experimental thiamine deficiency. J Neurosci Res 52:742-749
17. Hazell AS, Rao KV, Danbolt NC, Pow DV, Butterworth RF (2001) Selective down-regulation of the astrocyte glutamate transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke's encephalopathy. J Neurochem 78:560-568
18. Héroux M, Butterworth RF (1995) Regional alterations of thiamine phosphate esters and of thiamine diphosphate-dependent enzymes in relation to function in experimental Wernicke's encephalopathy. Neurochem Res 20:87-93
19. Iadecola C, Gorelick PB (2005) The Janus face of cyclooxygenase-2 in ischemic stroke: shifting toward downstream targets. Stroke 36:182-185
20. Iadecola C, Forster C, Nogawa S, Clark HB, Ross ME (1999) Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol (Berl) 98:9-14
21. Im JY, Kim D, Paik SG, Han PL (2006) Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radic Biol Med 41:960-972
22. Kennedy BP, Chan CC, Culp SA, Cromlish WA (1993) Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem Biophys Res Commun 197:494-500
23. Kruse M, Navarro D, Desjardins P, Butterworth RF (2004) Increased brain endothelial nitric oxide synthase expression in thiamine deficiency: relationship to selective vulnerability. Neurochem Int 45:49-56
24. Langlais PJ, Mair RG (1990) Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci 10:1664-1674
25. Langlais PJ, Anderson G, Guo SX, Bondy SC (1997) Increased cerebral free radical production during thiamine deficiency. Metab Brain Dis 12:137-143
26. Lleo A, Galea E, Sastre M (2007) Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases. Cell Mol Life Sci 64:1403-1418
27. Marcheselli VL, Bazan NG (1996) Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. J Biol Chem 271:24794-24799
28. 2 EP2 receptor in cerebral ischemia. J Neurosci 24:257-268
29. Miettinen S, Fusco FR, Yrjanheikki J, Keinanen R, Hirvonen T, Roivainen R, Narhi M, Hokfelt T, Koistinaho J (1997) Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci USA 94:6500-6505
30. Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63:901-910
31. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D (1983) The nucleotide sequence of rat cytoplasmic b-Actin gene. Nucleic Acid Res 11:1759-1771
32. Pannunzio P, Hazell AS, Pannunzio M, Rao KV, Butterworth RF (2000) Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy. J Neurosci Res 62:286-292
33. Pasinetti GM, Aisen PS (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87:319-324
34. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New York
35. 2 extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem 81:1028-1034
36. Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics methods and protocols: methods in molecular biology. Humana Press, Totowa, NJ, pp 365-386
37. Shimizu T, Wolfe LS (1990) Arachidonic acid cascade and signal transduction. J Neurochem 55:1-15
38. Takemiya T, Matsumura K, Yamagata K (2007) Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochem Int 51:112-120
39. Todd KG, Butterworth RF (1999) Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis. Glia 25:190-198
40. Wu L, Wang Q, Liang X, Andreasson K (2007) Divergent effects of prostaglandin receptor signaling on neuronal survival. Neurosci Lett 421:253-258
41. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11:371-386